期刊文献+

格列本脲蛋白结合作用的HPLC-FA法研究

HPLC-FA Study on the Protein Binding of Glibenclamide
下载PDF
导出
摘要 目的:建立高效液相色谱-迎头分析法(HPLC-FA)研究格列本脲与人血清白蛋白(HSA)的结合作用。方法:采用HPLC-FA法,色谱柱为 Pinkerton GFFⅡ-S5-80(150 mm×4.6 mm,5 μm),流动相为67 mmol·L^(-1)磷酸盐等渗缓冲液(pH 7.4,I=0.17 mol·L^(-1)),流速0.2 mL·min^(-1),检测波长230 nm,进样量900μL,柱温37℃。结果:应用非线性回归参数估算求得 HSA 分子上两类结合位点结合的格列本脲分子数及相应的结合平衡常数:n_1,=1.5和 K_1=1.1(μmol·L^(-1))^(-1);n_2=3.8和 K_2=0.012(μmol·L^(-1))^(-1)。结论:HPLC-FA 法操作简便,适用于研究格列本脲与 HSA 的结合作用。本实验选定的进样体积为900μL。 Objective:To develop HPLC - FA method for study of protein binding of glibenclamide. Methods: The separation is performed using Pinkerton GFF Ⅱ - S5 - 80 internal - surface reversed - phase silica support ( 150 mm ×4. 6 mm,5 μm)at pH 7.4 in a 67 mmol · L^-1 isotonic sodium phosphate buffer at 37 ℃. Other conditions included flow rate 0.2 mL · min^ - 1, UV detection at wavelength 230 nm and injection volume 900 μL. Resuits:Nonlinear regression parameter estimation is applicable to the association constants measurement of glibenclamide to both primary and secondary sites, which are 1.1 ( μmol · L^-1 )^ -1 and 1.5 for K1 and n1 , respectively,and 0. 012( μ mol · L^-1 )^ -1 and 3.8 for K2 and n2 ,respectively. Conclusions:The method is proved to be suit- able for investigation of protein binding of glibenclamide. The injection volume is 900 μL.
出处 《药物分析杂志》 CAS CSCD 北大核心 2005年第10期1176-1178,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 格列本脲 高效液相-迎头分析(HPLC-FA) 人血清白蛋白(HSA) 蛋白结合作用 人血清白蛋白 结合作用 高效液相色谱 非线性回归 检测波长 平衡常数 glibenclamide high performance liquid chromatography - frontal analysis ( HPLC - FA) human serum albumin(HSA) protein binding interaction
  • 相关文献

参考文献11

  • 1Wood GC, Cooper PF. The application of gel filtration to the study of protein - binding of small molecules. Chromatogr Rev, 1970,12:88.
  • 2Shibukawa A,Terakita A,He JY,et al. High -performance frontal analysis-high- performance liquid chromatographic system for stereoselective determination of unbound ketoprofen enantiomers in plasma after direct sample injection. J Pharm Sci, 1992,80:710.
  • 3Shibukawa A, Ishizawa N, Kimura T, et al. Plasma protein binding study of oxybutynin by high - performance frontal analysis method. J Chromatogr B ,2002,768 : 177.
  • 4Shibukawa A, Yoshikawa Y, Kimura T, et al, Binding study of desethyloxybutynin using high - performance frontal analysis method. J Chromatogr B,2002,768 : 189.
  • 5Shibukawa A, Nakagawa T, Nishimura N, et al. Determination of free drug in protein binding equilibrium by high - performance frontal analysis using internal - surface reversed - phase silica support. Chem Pharm Bull,1989,37:702.
  • 6乔明曦,郭兴杰,李发美.高效迎头分析法测定药物-人血清白蛋白混合液中游离药物浓度[J].色谱,2001,19(4):329-331. 被引量:4
  • 7Qiao MX, Guo X J, Li FM. Chemiluminescence detection coupled to high - performance frontal analysis for the determination of unbound concentrations of drugs in protein binding equilibrium. J Chromatogr A ,2002,952 : 131.
  • 8IA FM ,Qiao MX, Guo XJ. Specific determination of unbound oxacillin in protein solution with cefoperazone by high - performance frontal analysis with chemiluminescence detection. Biomed Chromatogr,2003,17(1) :53.
  • 9Crooks MJ, Brown KF. The binding of sulphonylureas to senun albumin. J Pharm Pharmacol, 1974,26 (5) :304.
  • 10Muller WE,Wollert U. Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin. Res Cornmun Chem Pathol Pharmacol, 1976,13 ( 3 ) :551.

二级参考文献1

  • 1Shibukawa A,J Pharm Sci,1992年,81卷,7期,710页

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部